TAK-003四价减毒活疫苗诱导的NS1特异性抗体应答强度与功能
本研究基于TAK-003四价减毒活疫苗候选株的2期临床试验血清,检测接种前后抗登革病毒NS1 IgG水平及其对NS1诱导的内皮高通透性的抑制作用。结果显示TAK-003在未感染过登革病毒者中显著提高DENV-2 NS1特异性IgG,且接种后所有血清均完全阻断DENV-2 NS1诱导的内皮高通透性并交叉抑制其他血清型NS1。
要点
- TAK-003可诱导功能性NS1特异性IgG应答
- 接种后血清完全阻断DENV-2 NS1诱导的内皮高通透性
- NS1特异性IgG浓度与抑制内皮高通透性相关
核心结论
- TAK-003四价减毒活疫苗候选株可诱导功能性NS1特异性IgG应答。
研究设计与样本
- 基于TAK-003的2期临床试验血清,使用酶联免疫吸附试验检测接种前后抗DENV NS1 IgG,并用体外内皮通透性模型评估功能。
主要发现
- TAK-003在未感染过登革病毒者中显著提高DENV-2 NS1特异性IgG,并与DENV-1、-3、-4 NS1有不同程度交叉反应。
- 接种前未感染者的血清不影响NS1诱导的内皮高通透性,而感染过者的血清有不同程度抑制。
- 接种后所有未感染和既往感染疫苗接受者的血清均完全阻断DENV-2 NS1诱导的高通透性,并交叉抑制DENV-1、-3、-4 NS1诱导的高通透性。
- NS1诱导高通透性的抑制与NS1特异性IgG浓度相关,接种后血清还阻止NS1诱导的内皮糖萼成分降解。
临床怎么用
- 提示NS1特异性IgG应答可作为登革疫苗功能性免疫原性评价指标。
- 为理解NS1抗体在阻断血管渗漏中的作用提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dengue virus (DENV) can cause life-threatening disease characterized by endothelial dysfunction and vascular leakage. DENV nonstructural protein 1 (NS1) induces human endothelial hyperpermeability and vascular leak in mice, and NS1 vaccination confers antibody-mediated protective immunity. We evaluated the magnitude, cross-reactivity, and functionality of NS1-specific IgG antibody responses in sera from a phase 2 clinical trial of Takeda's live-attenuated tetravalent dengue vaccine candidate (TAK-003). METHODS: We developed an enzyme-linked immunosorbent assay to measure anti-DENV NS1 IgG in sera from DENV-naive or preimmune subjects pre- and postvaccination with TAK-003 and evaluated the functionality of this response using in vitro models of endothelial permeability. RESULTS: TAK-003 significantly increased DENV-2 NS1-specific IgG in naive individuals, which cross-reacted with DENV-1, -3, and -4 NS1 to varying extents. NS1-induced endothelial hyperpermeability was unaffected by prevaccination serum from naive subjects but was variably inhibited by serum from preimmune subjects. After TAK-003 vaccination, all samples from naive and preimmune vaccinees completely abrogated DENV-2 NS1-induced hyperpermeability and cross-inhibited hyperpermeability induced by DENV-1, -3, and -4 NS1. Inhibition of NS1-induced hyperpermeability correlated with NS1-specific IgG concentrations. Postvaccination sera also prevented NS1-induced degradation of endothelial glycocalyx components. CONCLUSION: We provide evidence for functional NS1-specific IgG responses elicited by a candidate dengue vaccine. CLINICAL TRIALS REGISTRATION: NCT01511250.
引用
- Sharma M, Glasner DR, Watkins H, et al. Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate. J Infect Dis. 2020. PMID: 30783676. doi:10.1093/infdis/jiz081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。